Friday, September 11, 2020

PNB Vesper gets DCGI nod to test its experimental drug on Covid-19 patients

PNB Vesper gets DCGI nod to test its experimental drug on Covid-19 patients The company has filed the clinical trial application with the DCGI for the Phase 2 clinical trials, and the study will be completed in 60 days. The study will be conducted on 40 Covid-19 positive patients at BMJ Medical College, Pune.

from Moneycontrol Business News https://ift.tt/3hl9UrB
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...